[Federal Register Volume 83, Number 231 (Friday, November 30, 2018)]
[Notices]
[Pages 61650-61651]
[FR Doc No: 2018-26029]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-4116]

Bone, Reproductive and Urologic Drugs Advisory Committee; Notice
of Meeting; Establishment of a Public Docket; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; establishment of a public docket; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming
public advisory committee meeting of the Bone, Reproductive and
Urologic Drugs Advisory Committee. The general function of the
committee is to provide advice and recommendations to FDA on regulatory
issues. The meeting will be open to the public. FDA is establishing a
docket for public comment on this document.

DATES: The meeting will be held on January 16, 2019, from 8:15 a.m. to
5 p.m.

ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-
0002. Answers to commonly asked questions including information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm.
    FDA is establishing a docket for public comment on this meeting.
The docket number is FDA-2018-N-4116. The docket will close on January
14, 2019. Submit either electronic or written comments on this public
meeting by January 14, 2019. Please note that late, untimely filed
comments will not be considered. Electronic comments must be submitted
on or before January 14, 2019. The https://www.regulations.gov
electronic filing system will accept comments until 11:59 p.m. Eastern
Time at the end of January 14, 2019. Comments received by mail/hand
delivery/courier (for written/paper submissions) will be considered
timely if they are postmarked or the delivery service acceptance
receipt is on or before that date.
    Comments received on or before December 31, 2018, will be provided
to the committee. Comments received after that date will be taken into
consideration by FDA.
    You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-4116 for ``Bone, Reproductive and Urologic Drugs Advisory
Committee; Notice of Meeting; Establishment of a Public Docket; Request
for Comments.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' FDA will review
this copy, including the claimed confidential information, in its
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify the information as ``confidential.'' Any
information marked as ``confidential'' will not be disclosed except in
accordance with 21 CFR 10.20 and other applicable disclosure law. For
more information about FDA's posting of comments to public dockets, see
80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management

Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Kalyani Bhatt, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, Fax:<PHONE_NUMBER>, email: [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138<PHONE_NUMBER> in the
Washington, DC area). A notice in the Federal Register about last
minute modifications that impact a previously announced advisory
committee meeting cannot always be published quickly enough to provide
timely notice. Therefore, you should always check the FDA's website at
https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to
the appropriate advisory committee meeting link, or call the advisory
committee information line to learn about possible modifications before
coming to the meeting.

SUPPLEMENTARY INFORMATION:
    Agenda: The committee will discuss biologics license application
761062, romosozumab injection, submitted by Amgen, for the proposed
indication of treatment of osteoporosis in postmenopausal women at high
risk for fracture, defined as a history of osteoporotic fracture, or
multiple risk factors for fracture; or patients who have failed or are
intolerant of other available osteoporosis therapy.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its website prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's website after the meeting. Background material is
available at https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
All electronic and written submissions submitted to the Docket (see
ADDRESSES) on or before December 31, 2018, will be provided to the
committee. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. Those individuals interested in making
formal oral presentations should notify the contact person and submit a
brief statement of the general nature of the evidence or arguments they
wish to present, the names and addresses of proposed participants, and
an indication of the approximate time requested to make their
presentation on or before December 20, 2018. Time allotted for each
presentation may be limited. If the number of registrants requesting to
speak is greater than can be reasonably accommodated during the
scheduled open public hearing session, FDA may conduct a lottery to
determine the speakers for the scheduled open public hearing session.
The contact person will notify interested persons regarding their
request to speak by December 21, 2018.
    Persons attending FDA's advisory committee meetings are advised
that FDA is not responsible for providing access to electrical outlets.
    For press inquiries, please contact the Office of Media Affairs at
[email protected] or<PHONE_NUMBER>.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Kalyani Bhatt (see FOR FURTHER INFORMATION CONTACT) at least 7
days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our website at https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: November 26, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-26029 Filed 11-29-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: February 24, 2006 (Volume 71, Number 37)]
[Notices]
[Page 9543-9545]
[DOCID:fr24fe06-76]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[OARM-2006-0101; FRL-8036-7]

Establishment of New System of Records Notice for EZHIRE

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of Establishment of a New System of Records Notice for
EZHIRE.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the provisions of the Privacy Act of 1974 (5
U.S.C. 552a), the Office of Human Resources is giving notice that it
proposes to establish a new system of records, EZHire. This system of
records is a web-based hiring

management system that collects, maintains, monitor, and track
individuals filing employment applications with U.S. EPA and to assess
recruiting goals and objectives.

DATES: Persons wishing to comment on this new system of records notice
may do so by April 5, 2006. Unless there is a further notice in the
Federal Register, this system of records will become effective on April
5, 2006.

ADDRESSES: Questions regarding this notice should be referred to Rose
Ann Clark, Office of Human Resources, Ariel Rios East Building, 1200
Pennsylvania Ave., NW., Washington, DC 20460.

FOR FURTHER INFORMATION CONTACT: Rose Ann Clark or<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

General Information

    The EZHire system of records does not duplicate any existing
recruitment system of records. Details regarding the new system of
records are contained in this Federal Register Notice. The new system
is a web-based hiring management system for advertised vacancies that
allows individuals to file applications for employment with the U.S.
EPA in response to advertised position vacancy announcements. Access to
the system is restricted to authorized users and will be maintained in
a secure, password protected computer system, in secure areas and
buildings with physical access controls and environmental controls. The
system is maintained by the Office of Human Resources.
    EPA has established an official public docket for this action under
Docket ID No. EPA-HQ-OARM-2006-0101. The official public docket is the
collection of materials that is available for public viewing at the OEI
Docket in the EPA Docket Center, (EPA/DC) EPA West, Room B102, 1301
Constitution Ave., NW., Washington, DC. The EPA Docket Center Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Reading
Room is<PHONE_NUMBER>, and the telephone number for the OEI Docket is
(202) 566-1752.
    An electronic version of the public docket is available through
EPA's electronic public docket and comment system, EPA Dockets. You may
use EPA Dockets at http://www.epa.gov/edocket/ to view public comments,

access the index listing of the contents of the official public docket,
and to access those documents in the public docket that are available
electronically. Although not all docket materials may be available
electronically, you may still access any of the publicly available
docket materials through the docket facility identified above.

    Dated: February 15, 2006.
Linda A. Travers,
Acting Assistant Administrator and Chief Information Officer.
EPA-56

System Name:
    EZHIRE.

System Location:
    Human Resources Office, Personnel Services Branch, United States
Environmental Protection Agency (EPA) 1200 Pennsylvania Avenue,
Washington, DC 20640.

Categories of Individuals Covered By the System:
    Individuals filing applications for employment with the U.S.
Environmental Protection Agency in response to advertised position
vacancy announcements.

Categories of Records in the System:
    Position vacancy announcement information such as position title,
series and grade level(s), office and duty location, opening and
closing date of the announcement, and dates of referral and return of
lists of qualified candidates; applicant personal data such as name,
address, social security number, date of birth, sex, veterans'
preference and federal competitive status; and applicant qualification
and processing information such as qualifications, grade level
eligibility, reason for ineligibility, referral status, and dates of
notification.

Authority for Maintenance of the System:
    5 U.S.C. 1104, 5 U.S.C. 1302, 5 U.S.C. 3301, 5 U.S.C. 3304, 5
U.S.C., 3320, 5 U.S.C. 3327, 5 U.S.C. 3361, and 5 U.S.C. 3393;
Executive Order 9397 (Nov. 22, 1943).

Purpose(s):
    The records are collected and maintained to monitor, track and rank
qualified individuals filing employment applications with the U.S. EPA
and to assess recruiting goals and objectives. EZHire will improve
time-to-hire cycle, it will comply with the security requirements of
Federal Information Security Management Act (FISMA), collect Equal
Employment Opportunity (EEO) data and facilitate ad hoc reporting.

General Routine Uses of EPA Systems of Records:
    A. To the U.S. Office of Personnel Management, the Merit Systems
Protection Board, the Office of Government Ethics, the Office of
Special Counsel, the Federal Labor Relations Authority or its General
Counsel, the Equal Employment Opportunity Commission, to the extent
disclosure is determined to be relevant and necessary to carry out the
government-wide personnel management, investigatory, adjudicatory, and
appellate functions within their respective jurisdictions;
    B. To a congressional office in response to a written inquiry made
by a congressional office at the request of the individual to whom the
record pertains;
    C. To the appropriate Federal, State or local agency or responsible
authority, such information that is necessary and pertinent for
investigating or prosecuting a violation of, or for enforcing or
implementing a statute, rule, regulation, or order, when the
information indicates a violation or potential violation of law,
whether civil, criminal, or regulatory in nature, and whether arising
by general statute or particular program statute, or by regulation,
rule or order issued pursuant thereto;
    D. To a court, magistrate, or administrative tribunal in the course
of presenting evidence, including disclosures to counsel or witnesses
in the course of civil discovery, litigation, or settlement
negotiations or in connection with criminal proceedings, when the U.S.
EPA is a party to the proceeding or has a significant interest in the
proceeding and the information is determined to be relevant and
necessary; and
    E. To a consultant, person or entity who contracts or subcontracts
with the U.S. EPA, to the extent necessary for the performance of the
contract or subcontract. The recipient of the records shall be required
to comply with the requirements of the Privacy Act of 1974, as amended
(5 U.S.C. 552a).

Policies and Practices for Storing, Retrieving, Accessing, Retaining,
and Disposing of Records in the System:
Storage:
    Records are stored in electronic media and paper format.

Retrievability:
    Indexed and retrieved by name and social security number of
individual applicant.

Safeguards:
    Electronic files are password protected and accessible only by
authorized personnel (Human Resources Specialist who are assigned to
this task). Network servers are located in a locked

room with physical access limited to only authorized personnel such as
IT personnel.

Retention and Disposal:
    Personal data that is collected from the individual is maintained
for two years after which all data is removed in accordance with
National Archives and Records Administration procedures.

System Manager(s) and Address:
    Acting Director, Office of Human Resources, U.S. Environmental
Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460.

Notification Procedure:
    An Individual wishing to determine if they are named in this system
of records or gain access to records maintained in this system must be
a registered user. (If you have previously applied for employment enter
your online applicant User ID (or e-mail address) plus your Password to
view or edit the application, personal data or your resume.)

Record Access Procedures:
    An individual wishing to determine if they are named in this system
of records or gain access to records maintained in this system must be
a Registered User.

Contesting Record Procedures:
    An individual wishing to contest or amend information maintained in
this system should be a Registered User.

Record Source Categories:
    None.
    Information originates from position vacancy announcements, and
applications for employment submitted by individuals.

Exemptions Claimed for The System:
    None.
[FR Doc. 06-1738 Filed 2-23-06; 8:45 am]

BILLING CODE 6560-50-P


[Federal Register Volume 83, Number 238 (Wednesday, December 12, 2018)]
[Proposed Rules]
[Page 63817]
[FR Doc No: 2018-26934]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 93

RIN 2120-AK39

Notification of Replacement Public Meeting on Requirement for
Helicopters To Use the New York North Shore Helicopter Route

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notification of public meeting.

-----------------------------------------------------------------------

SUMMARY: Due to inclement weather on November 15, 2018, the FAA
announces a replacement public meeting to solicit feedback concerning
the New York North Shore Helicopter Rule (``the Rule''). This meeting
is being held pursuant to Section 182 of the FAA Reauthorization Act of
2018. The Rule requires civil helicopter pilots operating under Visual
Flight Rules (VFR), whose route of flight takes them over the north
shore of Long Island between the Visual Point Lloyd Harbor (VPLYD)
waypoint and Orient Point (VPOLT), to use the North Shore Helicopter
Route.

DATES: The public meeting will be held on Thursday, December 13, 2018.

ADDRESSES: The public meeting will be held at Vaugh College, 8601 23rd
Avenue, Flushing NY 11369. The meeting is 7:00 p.m.-9:00 p.m. EST.

FOR FURTHER INFORMATION CONTACT: Christopher Bailey, Office of
Rulemaking, Federal Aviation Administration; telephone<PHONE_NUMBER>;
email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Purpose of the Public Meeting

    The purpose of the public meeting is for the FAA to obtain feedback
relevant to the Rule at subpart H of part 93, which requires civil
helicopter pilots operating under VFR, whose route of flight takes them
over the north shore of Long Island between the VPLYD waypoint and
VPOLT, to use the North Shore Helicopter Route. The FAA will consider
comments made at the public meeting in its review of the Rule.

Public Participation and Meeting Procedures

    The meeting will use a workshop format. FAA will have several
stations covering a number of relevant aspects of the Rule. Each
station will be staffed by an FAA representative who is able to answer
questions regarding that subject. There will also be a station where
the public can submit a written statement or have their oral comment
transcribed. No formal presentations will be made.
    Section 182 of the FAA Reauthorization Act of 2018 also calls for a
written comment period on the North Shore Helicopter Rule. See docket
number FAA-2018-0954 to submit written comments.
    Sign and oral interpretation can be made available at the meeting,
as well as an assistive listening device, if requested 3 calendar days
before the meeting. The meeting will be open to all persons on a space-
available basis. There will be no admission fee or other charge to
attend and participate.

    Issued in Washington, DC, on December 7, 2018.
Brandon Roberts,
Deputy Executive Director, Office of Rulemaking.
[FR Doc. 2018-26934 Filed 12-10-18; 4:15 pm]
 BILLING CODE 4910-13-P


[Federal Register Volume 88, Number 201 (Thursday, October 19, 2023)]
[Notices]
[Pages 72116-72117]
[FR Doc No: 2023-23036]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-98746; File No. 10-240]

MIAX Sapphire, LLC; Notice of Filing of Application for
Registration as a National Securities Exchange Under Section 6 of the
Securities Exchange Act of 1934

October 13, 2023.
    On September 26, 2023, MIAX Sapphire, LLC (``MIAX Sapphire'' or
``Applicant'') submitted to the Securities and Exchange Commission
(``Commission'') a Form 1 application under the Securities Exchange Act
of 1934 (``Exchange Act''), seeking registration as a national
securities exchange under section 6 of the Exchange Act.
    The Commission is publishing this notice to solicit comments on
MIAX Sapphire's Form 1 application. The Commission will take any
comments it receives into consideration in making its determination
about whether to grant MIAX Sapphire's request to be registered as a
national securities exchange. The Commission will grant the
registration if it finds that the requirements of the Exchange Act and
the rules and regulations thereunder with respect to MIAX Sapphire are
satisfied.\1\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(a).
---------------------------------------------------------------------------

    The Applicant's Form 1 application provides detailed information on
how MIAX Sapphire proposes to satisfy the requirements of the Exchange
Act. The Form 1 application also provides that MIAX Sapphire would
operate a fully automated electronic trading platform for the trading
of listed options. It also provides that liquidity would be derived
from quotes as well as orders to buy and orders to sell submitted to
MIAX Sapphire electronically by its registered broker-dealer members
from remote locations. The Form 1 application further provides that
there would be a physical trading floor located in Miami, Florida. MIAX
Sapphire would have two types of members on the electronic trading
platform, market makers and electronic exchange members, and two types
of floor participants, floor brokers and floor market makers. Further,
the Form 1 application states that MIAX Sapphire would be wholly-owned
by its parent company, Miami International Holdings, Inc. (``Miami
Holdings''), which is also the parent company of four existing national
securities exchanges, Miami International Securities Exchange, LLC,
MIAX PEARL, LLC, MIAX Emerald, LLC, and Minneapolis Grain Exchange,
LLC.\2\
---------------------------------------------------------------------------

    \2\ Minneapolis Grain Exchange, LLC is also a designated
contract market and derivatives clearing organization that operates
under the regulatory oversight of the Commodity Futures Trading
Commission pursuant to section 5 of the Commodity Exchange Act. 7
U.S.C. 7.
---------------------------------------------------------------------------

    A more detailed description of the manner of operation of MIAX
Sapphire's proposed system can be found in Exhibit E to MIAX Sapphire's
Form 1 application. The proposed rulebook for the proposed exchange can
be found in Exhibit B to MIAX Sapphire's Form 1 application, and the
governing documents for both MIAX Sapphire and Miami Holdings can be
found in Exhibit A and Exhibit C to MIAX Sapphire's Form 1 application,
respectively. A listing of the officers and directors of MIAX Sapphire
can be found in Exhibit J to MIAX Sapphire's Form 1 application. A
complete set of forms concerning membership and access can be found in
Exhibit F to MIAX Sapphire's Form 1 application.
    MIAX Sapphire's Form 1 application, including all of the Exhibits
referenced above, is available online at www.sec.gov/rules/other.shtml
as well as in the Commission's Public Reference Room. Interested
persons are invited to submit written data, views, and

arguments concerning MIAX Sapphire's Form 1, including whether the
application is consistent with the Exchange Act.
    Comments may be submitted by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/other.shtml); or
     Send an email to [email protected]. Please include
File Number 10-240 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number 10-240. This file number
should be included on the subject line if email is used. To help the
Commission process and review your comments more efficiently, please
use only one method. The Commission will post all comments on the
Commission's internet website (http://www.sec.gov/rules/other.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to MIAX Sapphire's Form 1 filed with the
Commission, and all written communications relating to the application
between the Commission and any person, other than those that may be
withheld from the public in accordance with the provisions of 5 U.S.C.
552, will be available for website viewing and printing in the
Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549, on official business days between the hours of 10 a.m. and 3
p.m. Copies of the filing also will be available for inspection and
copying at the principal office of the Exchange. Do not include
personal identifiable information in submissions; you should submit
only information that you wish to make available publicly. We may
redact in part or withhold entirely from publication submitted material
that is obscene or subject to copyright protection.
    All submissions should refer to File Number 10-240 and should be
submitted on or before December 4, 2023.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\3\
---------------------------------------------------------------------------

    \3\ 17 CFR 200.30-3(a)(71)(i).

Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2023-23036 Filed 10-18-23; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 80, Number 120 (Tuesday, June 23, 2015)]
[Notices]
[Pages 35951-35952]
[FR Doc No: 2015-15460]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9929-53-OGC]

Proposed Consent Decree, Clean Air Act Citizen Suit

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of proposed consent decree; request for public comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 113(g) of the Clean Air Act, as
amended (``CAA'' or the ``Act''), notice is hereby given of a proposed
consent decree to address a lawsuit filed by the Environmental
Integrity Project: Environmental Integrity Project v. McCarthy, No.
1:14-cv-2106 (RC) (D. D.C.). On December 12, 2014, Plaintiff filed a
complaint alleging that Gina McCarthy, in her official capacity as
Administrator of the United States Environmental Protection Agency
(``EPA''), failed to perform a non-discretionary duty to grant or deny
within 60 days two petitions submitted by the Environmental Integrity
Project on May 19, 2014, requesting that EPA object to two CAA Title V
permits issued by the Texas Commission on Environmental Quality
(``TCEQ'') to the Shell Chemical Company and the Shell Oil Company
authorizing the operation of the Deer Park Chemical Plant and the Deer
Park Refinery, respectively, located in Harris County, Texas. The
proposed consent decree would establish a deadline of August 21, 2015,
for EPA to take such action.

DATES: Written comments on the proposed consent decree must be received
by July 23, 2015.

ADDRESSES: Submit your comments, identified by Docket ID number EPA-HQ-
OGC-2015-0364, online at www.regulations.gov (EPA's preferred method);
by email to<EMAIL_ADDRESS>by mail to EPA Docket Center,
Environmental Protection Agency, Mailcode: 2822T, 1200 Pennsylvania
Ave. NW., Washington, DC 20460-0001; or by hand delivery or courier to
EPA Docket Center, EPA West, Room 3334, 1301 Constitution Ave. NW.,
Washington, DC, between 8:30 a.m. and 4:30 p.m. Monday through Friday,
excluding legal holidays. Comments on a disk or CD-ROM should be
formatted in Word or ASCII file, avoiding the use of special characters
and any form of encryption, and may be mailed to the mailing address
above.

FOR FURTHER INFORMATION CONTACT: Richard H. Vetter, Air and Radiation
Law Office, Office of General Counsel, U.S. Environmental Protection
Agency, c/o US/EPA/OAQPS/SPPD/IO D205-01, Research Triangle Park, North
Carolina 27711; telephone:<PHONE_NUMBER>; fax number<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Additional Information About the Proposed Consent Decree

    The proposed consent decree would resolve a lawsuit filed by the
Environmental Integrity Project seeking to compel the Administrator to
take actions under CAA section 505(b)(2). Under the terms of the
proposed consent decree, EPA would agree to sign its response granting
or denying the petitions filed by the Environmental Integrity Project
regarding Shell Chemical Company's Deer Park Chemical Plant and Shell
Oil Company's Deer Park Refinery, both located in Harris County, Texas,
pursuant to section 505(b)(2) of the CAA, on or before August 21, 2015.
    Under the terms of the proposed consent decree, EPA would
expeditiously deliver notice of EPA's response to the Office of the
Federal Register for review and publication following signature of such
response. In addition, the proposed consent decree outlines the
procedure for the Plaintiffs to request costs of litigation, including
attorney fees.
    For a period of thirty (30) days following the date of publication
of this notice, EPA will accept written comments relating to the
proposed consent decree from persons who are not named as parties or
intervenors to

the litigation in question. EPA or the Department of Justice may
withdraw or withhold consent to the proposed consent decree if the
comments disclose facts or considerations that indicate that such
consent is inappropriate, improper, inadequate, or inconsistent with
the requirements of the Act. Unless EPA or the Department of Justice
determines that consent to this consent decree should be withdrawn, the
terms of the consent decree will be affirmed.

II. Additional Information About Commenting on the Proposed Consent
Decree

A. How can I get a copy of the consent decree?

    The official public docket for this action (identified by Docket ID
No. EPA-HQ-OGC-2015-0364) contains a copy of the proposed consent
decree. The official public docket is available for public viewing at
the Office of Environmental Information (OEI) Docket in the EPA Docket
Center, EPA West, Room 3334, 1301 Constitution Ave. NW., Washington,
DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to
4:30 p.m., Monday through Friday, excluding legal holidays. The
telephone number for the Public Reading Room is<PHONE_NUMBER>, and the
telephone number for the OEI Docket is<PHONE_NUMBER>.
    An electronic version of the public docket is available through
www.regulations.gov. You may use www.regulations.gov to submit or view
public comments, access the index listing of the contents of the
official public docket, and to access those documents in the public
docket that are available electronically. Once in the system, key in
the appropriate docket identification number then select ``search.''
    It is important to note that EPA's policy is that public comments,
whether submitted electronically or in paper, will be made available
for public viewing online at www.regulations.gov without change, unless
the comment contains copyrighted material, CBI, or other information
whose disclosure is restricted by statute. Information claimed as CBI
and other information whose disclosure is restricted by statute is not
included in the official public docket or in the electronic public
docket. EPA's policy is that copyrighted material, including
copyrighted material contained in a public comment, will not be placed
in EPA's electronic public docket but will be available only in
printed, paper form in the official public docket. Although not all
docket materials may be available electronically, you may still access
any of the publicly available docket materials through the EPA Docket
Center.

B. How and to whom do I submit comments?

    You may submit comments as provided in the ADDRESSES section.
Please ensure that your comments are submitted within the specified
comment period. Comments received after the close of the comment period
will be marked ``late.'' EPA is not required to consider these late
comments.
    If you submit an electronic comment, EPA recommends that you
include your name, mailing address, and an email address or other
contact information in the body of your comment and with any disk or CD
ROM you submit. This ensures that you can be identified as the
submitter of the comment and allows EPA to contact you in case EPA
cannot read your comment due to technical difficulties or needs further
information on the substance of your comment. Any identifying or
contact information provided in the body of a comment will be included
as part of the comment that is placed in the official public docket,
and made available in EPA's electronic public docket. If EPA cannot
read your comment due to technical difficulties and cannot contact you
for clarification, EPA may not be able to consider your comment.
    Use of the www.regulations.gov Web site to submit comments to EPA
electronically is EPA's preferred method for receiving comments. The
electronic public docket system is an ``anonymous access'' system,
which means EPA will not know your identity, email address, or other
contact information unless you provide it in the body of your comment.
In contrast to EPA's electronic public docket, EPA's electronic mail
(email) system is not an ``anonymous access'' system. If you send an
email comment directly to the Docket without going through
www.regulations.gov, your email address is automatically captured and
included as part of the comment that is placed in the official public
docket, and made available in EPA's electronic public docket.

    Dated: June 15, 2015.
Lorie J. Schmidt,
Associate General Counsel.
[FR Doc. 2015-15460 Filed 6-22-15; 8:45 am]
 BILLING CODE 6560-50-P